SubjectWell Raises $10M to Expand Its Risk-Free Patient Recruitment Marketplace
AUSTIN, Texas–(BUSINESS WIRE)–SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today its $10 million in Series A funding…
Pharmaceuticals, Biotechnology and Life Sciences
AUSTIN, Texas–(BUSINESS WIRE)–SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today its $10 million in Series A funding…
Expansion of Board of Directors Adds Commercialization and Financial Expertise, Further Augments Clinical and Scientific Acumen of Medical and Scientific…
DALLAS–(BUSINESS WIRE)–Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of…
MONTGOMERY, Ala.–(BUSINESS WIRE)–Kowa Pharmaceuticals America, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the cholesterol-lowering…
DUBLIN–(BUSINESS WIRE)–The “Cephalosporin Drugs: Global Market Analysis & Outlook 2019-2024” report has been added to ResearchAndMarkets.com’s offering. Market Overview The…
LONDON–(BUSINESS WIRE)–#Biotechnology–According to Technavio Research Report “Human Immunodeficiency Virus (HIV) Rapid Test Kits Market by end-user (diagnostic centers; and hospitals…
Company will use funds to scale its Cara Care digital therapeutic for life-interrupting digestive diseases BERLIN–(BUSINESS WIRE)–#GERD–Digital health company HiDoc…
Darlene Deptula-Hicks appointed new Chief Financial Officer Tolga Hassan appointed Chief Operating Officer Lindsey Trickett appointed VP, Investor Relations and…
Clinical trials of TAC01-CD19 expected to begin in third quarter 2019 AUSTIN, Texas & HAMILTON, Ontario–(BUSINESS WIRE)–Triumvira Immunologics, Inc. (Triumvira),…
NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces that patient…